THE CURRENT STATUS OF INTERFERON-ALPHA IN HEMIC MALIGNANCY

被引：11

作者：

GALVANI, DW

CAWLEY, JC

机构：

[1] University Department of Haematology, Royal Liverpool Hospital, Liverpool, L69 3BX, 3rd Floor, Duncan Building, Prescot St.

来源：

BLOOD REVIEWS | 1990年 / 4卷 / 03期

关键词：

D O I：

10.1016/0268-960X(90)90045-T

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Interferon-α (IFNα) has been extensively studied, both in clinical trials and in the laboratory. The cytokine has proved most effective in haemic malignancy, in particular hairy cell and chronic granulocytic leukaemia. This article deals with the current status of IFNα in these conditions and the possible basis of this sensitivity. Other less responsive haemic malignancies are also discussed. © 1990.

引用

页码：175 / 180

页数：6

共 50 条

[1]

ALIMENA G, 1988, BLOOD, V72, P642

[2]

ALLAN NC, 1987, CHRONIC MYELOID LEUK, P1031

[3]

BROXMEYER HE, 1983, J IMMUNOL, V131, P1300

[4]

BUNN PA, 1986, CANCER, V57, P1689, DOI 10.1002/1097-0142(19860415)57:8+<1689::AID-CNCR2820571311>3.0.CO

[5]

2-M

[6]

CONSTANZI JJ, 1985, J CLIN ONCOL, V3, P654

[7]

CUNNINGHAM I, 1979, BLOOD, V53, P375

[8] HETEROGENEITY OF CLL - HIGH CD23 ANTIGEN AND ALPHA-IFN RECEPTOR EXPRESSION ARE FEATURES OF FAVORABLE DISEASE AND OF CELL ACTIVATION [J].

DADMARZ, R ;

CAWLEY, JC .

BRITISH JOURNAL OF HAEMATOLOGY, 1988, 68 (03) :279-282

[9]

DOWDING CR, 1987, EXP HEMATOL, V15, P441

[10]

ELIAS L, 1987, LEUKEMIA, V1, P105

← 1 2 3 4 5 →